SCHEMBL12873263

SCHEMBL12873263

C(C#Cc1ccncc1)#Cc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.52
GRM5 P41594 3/20 0.48
NOTUM Q6P988 1/20 0.46
HDAC8 Q9BY41 1/20 0.44
PIK3CD O00329 1/20 0.43
PIK3CA P42336 1/20 0.43
MTOR P42345 1/20 0.43
PIK3CG P48736 1/20 0.43
PDK1 Q15118 1/20 0.43
SLC6A2 P23975 1/20 0.41
SLC6A4 P31645 1/20 0.41
SLC6A3 Q01959 1/20 0.41
MAPT P10636 1/20 0.41
FFAR1 O14842 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
THPO P40225 1/20 0.39
GRM4 Q14833 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2925968 0.90 APP (0.67) APPGRM5NOTUMHDAC8PIK3CD
SCHEMBL1190707 0.89 HDAC8 (0.52) GRM5NOTUMHDAC8PIK3CDPIK3CA
SCHEMBL17224548 0.87 APP (0.63) APPGRM5NOTUMHDAC8PIK3CD
Benzene SCHEMBL28733255 0.84 APP (0.73) APPGRM5MTORMAPTFFAR1
SCHEMBL403663 0.84 APP (0.73) APPGRM5MTORMAPTFFAR1
SCHEMBL30495998 0.84 APP (0.73) APPGRM5MTORMAPTFFAR1
SCHEMBL17312253 0.84 APP (0.73) APPGRM5MTORMAPTFFAR1
SCHEMBL9610050 0.81 APP (0.55) APPGRM5NOTUMPIK3CDPIK3CA
SCHEMBL9121457 0.81 APP (0.69) APPGRM5MTORMAPTFFAR1
SCHEMBL7108385 0.78 HDAC8 (0.76) GRM5HDAC8PIK3CDPIK3CAMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110024691-A1 AROMATIC AND AROMATIC/HETEROAROMATIC MOLECULAR STRUCTURES WITH CONTROLLABLE ELECTRON CONDUCTING PROPERTIES E. I. DU PONT DE NEMOURS AND COMPANY (US) 2011-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110024691-A1 AROMATIC AND AROMATIC/HETEROAROMATIC MOLECULAR STRUCTURES WITH CONTROLLABLE ELECTRON CONDUCTING PROPERTIES AHR, TYR, ARNT APP 1595/4885GRM5 4146/4885NOTUM 4721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.